Healthcare Logistics Market Analysis

  • Report ID: 6865
  • Published Date: Sep 18, 2025
  • Report Format: PDF, PPT

Healthcare Logistics Market Segmentation:

Product Segment Analysis    

By 2035, medical devices segment is anticipated to account for healthcare logistics market share of around 51.8%. The growing demand for diagnostic tools, in addition to the increasing prevalence of chronic diseases, and rising surgical procedures drive the need for efficient and timely logistic solutions. The developing economies around the world are importing a wide range of medical devices, majorly from the U.S.

For instance, according to the OEC, in 2022, the U.S. exported USD 33.3 billion in medical instruments, becoming the first largest exporter of medical instruments in the world. Additionally, in 2022, medical instruments were the eleventh most exported products from the U.S. to countries including the Netherlands (USD 5.4 billion), China (USD 3.7 billion), Mexico (USD 3.2 billion), Japan (USD 2.4 billion), and Germany (USD 2.4 billion). This in turn is boosting the market growth further.

Type Segment Analysis    

Based on type, the generic drugs segment is projected to dominate the healthcare logistics market during the forecast period. Generic drugs form the basic layer of hospital and preventive healthcare and comprise the vast majority of shortages. The increasing demand for affordable medicines has boosted the production and distribution of generic drugs. These drugs also benefit from streamlined logistics, as they typically have less stringent storage requirements, allowing efficient large-scale transportation and accessibility across the diverse market.

For instance, according to the CPA, in the U.S. generic pharmaceuticals were the second largest manufactured import, with a value of USD 176 billion in imported products in 2021. India, Mexico, and China held 57% of all pharmaceutical imports (by weight) in 2021. In addition, 84% of all prescription volume in the U.S. includes generics in comparison to 35% in other OECD nations, paying USD 0.8 for generic drugs compared to other OECD nations. In 2019, the U.S. FDA approved more than 1,100 generic drugs under the abbreviated new drug application (ANDA). This has promoted the demand for generic drugs, in turn boosting the transport demand in the market.

Our in-depth analysis of the global market includes the following segments:

Type

  • Branded Drugs
  • Generic Drugs

Product

  • Pharmaceutical Products
  • Medical Devices
  • Medical Equipment

Service

  • Transportation
  • Warehousing

End users

  • Pharmacies
  • Healthcare Facilities
  • Research and Diagnostic Laboratories

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of healthcare logistics is evaluated at USD 112.01 billion.

The global healthcare logistics market size was worth over USD 103.7 billion in 2025 and is poised to grow at a CAGR of over 8.9%, reaching USD 243.25 billion revenue by 2035.

North America healthcare logistics market will account for 45.80% share by 2035, driven by a well-established pharmaceutical industry and robust supply chain infrastructure.

Key players in the market include DHL Supply Chain, UPS Healthcare (United Parcel Service, Inc.), FedEx Corporation, Kuehne+Nagel International AG, DB Schenker, CEVA Logistics, XPO Logistics, Inc., Cardinal Health, Inc., Owens & Minor, Inc., AmerisourceBergen Corporation (Cencora).
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos